🌟 A big thank you to Dr. Morag Park for her enlightening presentation at today's adMare Industry Builder Series! Dr. Park's insights into the latest advancements in cancer research and her dedication to innovation truly exemplify the spirit of collaboration and progress that drives the life sciences industry forward. We are grateful for the opportunity to learn from her expertise and look forward to seeing the continued impact of her groundbreaking work. The recording of the webinar will be available on the adMare Community soon. Join today for free and access the entire library of our webinar series recordings ➡️community.admarebio.com #CancerResearch #Innovation #LifeSciences --- 🌟 Un grand merci à la Dre Morag Park pour sa présentation éclairante lors du webinaire de la série des développeurs de l'industrie adMare d'aujourd'hui ! Les idées de la Dre Park sur les dernières avancées en matière de recherche sur le cancer et son dévouement à l'innovation illustrent véritablement l'esprit de collaboration et de progrès qui fait avancer l'industrie des sciences de la vie. Nous lui sommes reconnaissants de nous avoir donné l'occasion de profiter de son expertise et nous sommes impatients de découvrir l'impact de ses travaux novateurs. L'enregistrement du webinaire sera bientôt disponible sur la Communauté adMare. Inscrivez-vous gratuitement dès aujourd'hui et accédez à l'ensemble de la bibliothèque des enregistrements de notre série de webinaires ➡️community.admarebio.com #RechercheSurLeCancer #Innovation #SciencesDeLaVie
Post de adMare BioInnovations
Plus de posts pertinents
-
In our current series, we are introducing our project's public deliverables - their aim, impact, and the future steps they are the building blocks of. 💡 EOSC4Cancer's Deliverable 1.1 builds upon the outcomes of the project's Deliverable 1.3, consolidating a sustainable Data Resources Map. This deliverable, like its predecessor, is authored by Work Package 1 partner UMCG ambulancezorg. The complex nature of cancer requires integration of advanced research data across national boundaries to enable progress in prevention and care. The vision of this deliverable is to create such a European sustainable catalogue. Read more about the deliverable here: emp.onl/RYQNM #FAIRdata #cancerdata #datasharing
Identifiez-vous pour afficher ou ajouter un commentaire
-
Lung cancer could be spotted and treated more quickly thanks to a €12 million investment in cutting-edge technology that promises to diagnose and treat disease in minutes rather than weeks. The investment will launch a spinout company from the Universities of Edinburgh and Bath, named Prothea Technologies Ltd, which is developing tech to ‘see and treat’ diseased tissue in a one-stop procedure. Dr John Lonsdale, Head of Enterprise at Edinburgh Innovations, said: “Prothea Technologies has emerged from an ambitious collaboration between the Universities of Edinburgh, Bath, Dundee and Durham, alongside NHS Lothian and Heriot-Watt University. Its journey so far has shaped pioneering science into a tangible solution for crucial unmet clinical needs. Edinburgh Innovations is delighted to have supported that journey, and we look forward to seeing Prothea move into its next chapter: to transform the lives of patients and their families.” Read more ➡ https://eil.ac/prothea/L The University of Edinburgh| University of Dundee| Durham University| University of Bath| #innovation #collaboration #research #cancerresearch #lungcancer #technology
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
Yesterday, ONCOSCREEN participated in the first meeting of "Prevention, including Screening” and "Understanding" of the #EU Mission Cancer clusters. The LUCIA EU Project hosted the meeting in San Sebastián and 🌐 online. After a presentation from the European Health and Digital Executive Agency (HaDEA) representative, Marianne Da Silva, all projects were introduced. Anax Fotopoulos (EXUS AI LABS) presented #ONCOSCREEN to participants. The meeting also included envigorating discussions on the future collaborative opportunities for advancing #CancerResearch, including such topics as: ▫ Research and innovation updates ▫ Data management ▫ Citizen engagement ▫ Communication and dissemination strategy 👏 Many thanks to the team of LUCIA EU Project for a great start to the annual cluster meetings. #HorizonEurope #EUCancerMission #CancerPlan #CancerResearch #Clustering #CancerAwareness #ColorectalCancer
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
Co-Founder and Director @ heoRlytics | Head, Modeling and Advanced Analytics @ Pharmacoevidence| Expert R Shiny Developer | HTA | HEOR
🌟 Join us at ISPOR Copenhagen! 🌟 🔍 Curious about the latest insights in health technology assessment? Pharmacoevidence unveiling three groundbreaking posters that dive into the cutting-edge landscape of healthcare analytics. 1. 🇸🇪 "A Review of Approved Managed Entry Agreements in Sweden" Uncover the intricacies of Sweden's managed entry agreements and their impact on healthcare access. 2. 🫁 "Review of Survival Modeling Approaches in NICE TAs for NSCLC" Explore the innovative survival modeling techniques adopted in NICE Technology Appraisals for Non-Small Cell Lung Cancer. 3. 📊 "Web Tool Development for Meta-Analysis of Kaplan-Meier Curves" Discover how our new web tool simplifies the complex process of performing meta-analysis on Kaplan-Meier curves from diverse studies. To dive deeper into these posters or explore our capabilities, swing by Booth C3-076 at ISPOR Copenhagen. Let's connect and discuss the future of healthcare analytics together! #ISPORCopenhagen #HealthTech #Analytics #isporeurope #ispor #pharmacoevidence
Identifiez-vous pour afficher ou ajouter un commentaire
-
Wow!!! We are thrilled to be selected by the European Innovation Council, EIC to receive a €2.5 million grant - not for our technology itself, but for the potential to transform cancer care and improve lives for millions of patients globally!🙏🏻 The EIC Accelerator supports game-changing "deep tech" innovations with the ability to create new markets or disrupt existing ones. Only a few companies make it through their rigorous multi-step evaluation process. Multi4 Medical's world-first automated endoscopic system solves a major problem by enabling fast, efficient cancer diagnosis and treatment in a single procedure. That only takes some minutes! The patient is awake and goes home immediately afterwards- no more hospital care! We start with bladder cancer where the patient benefits are very high and the healthcare make big cost savings. We are passionate about improving lives through medical breakthroughs. This is a major milestone towards bringing our game-changing technology to patients worldwide. I'm soo grateful for all the amazing people and partners joining us on this journey - without you, this would not have been possible! Thank you!🙏🏻😊 Photo: Cecilia Nilsen Palm, Jönköpingsposten Erik Selin Ulf Rosén Fredrik Strömholm Simon Angeldorff Arnt Larsen Lund Robert Wahlquist Olle Granath Lars-Peter Harbing Henrik Engqvist Mona Mirmoradi Erik Gatenholm #bladdercancer #medtech #EIC European Innovation Council and SMEs Executive Agency (EISMEA) #Multi4 #endoscopy
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
"Surround yourself with those who challenge your thinking; within the diversity of thought, lies the fertile ground for growth." - Anonymous The Indian Cancer Congress stands as the ultimate gathering of dedicated cancer researchers, oncologists, and corporate entities deeply invested in the fight against cancer. Presenting VarSee to this diverse and distinguished audience was an enriching experience, offering us a wealth of knowledge, invaluable feedback, and a renewed confidence in our product. Engaging in conversations with numerous healthcare professionals, it became abundantly clear that there exists a pressing need for an affordable and accessible cancer screening tool. Such a tool would not only alleviate the healthcare burden but also mitigate the financial strain on families and entire nations, ultimately leading to lives saved. The eagerness displayed by these medical experts to embrace our product has injected a fresh surge of enthusiasm into our team, motivating us to expedite our product's development and market entry. 🚀💪 #healthcareinnovation #researchanddevelopment
Our Chief Scientific Officer, Snahlata Singh, had the privilege of showcasing VarSee at the Indian Cancer Congress 2023. We were thrilled to receive valuable insights and foster promising collaborations. This event was a fantastic platform for networking, bringing together professionals from diverse fields including surgical and medical oncologists, preventive oncologists, and oncology firms. It was particularly heart warming to see advances in precision oncology and higher adoption of the same in clinics. Receiving accolades and feedbacks from experienced oncologists boosted our morale to continue on our path of developing VarSee and commercializing it soon! #Indiancancercongress2023 #Science #Medicine
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
This #CancerPreventionActionWeek2024, remember that knowledge is power! Detecting lung cancer in the early stages could provide a valuable window for early intervention Prevention is an important step towards well-being and everyone should have access to it. SOLACE is working towards breaking down lung cancer screening barriers, to ensure people across all social and economic groups can access it. 👉 Learn more about it here https://lnkd.in/eukiSx7N #CPAW #SOLACELUNG #HealthUnion #EUCancerPlan #EU4Health The European Institute for Biomedical Imaging Research (EIBIR) European Society of Radiology European Lung Foundation European Health and Digital Executive Agency (HaDEA)
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
We hope the sun is shining wherever you are today as we bring you the latest #FridayRoundup updates from our portfolio! ☀️ 🌟Rounding off a busy month, SENISCA was featured in Sifted today in its March wrap-up! Check out the full story here: https://lnkd.in/em3-_fjD 🏆 Quibim announces the winner of the The CHAIMELEON Project The open challenges are part of The CHAIMELEON Project, of which Quibim is a key member. Participants of the challenge were faced with tasks individually tailored to address specific cancer types - prostate, lung, breast, colon, and rectum. The competition winners will receive a share of the €100,000 prize money. https://lnkd.in/eWHvb6_c 👏 ImageBiopsy Lab's #IBLab #Flamingo nominated for Houska Award 2024 The Houska Award is Austria’s largest private award for applied research, celebrating outstanding research projects that drive economic growth and innovation within the country. ImageBiopsy Lab was chosen out of 73 submissions, and the winner will be announced on the 25th April, 2024. https://lnkd.in/eVYSGdMj 🗞️ CardiaTec Biosciences features in The Guardian The feature was part of the Guardian’s Health Awareness campaign, bringing people’s attention to CardiaTec’s work in helping solve cardiovascular disease. https://lnkd.in/eVgjYVfZ 🧅 Morpher opens up onions trading market 😃 You read this right! It is now possible to trade onions 🧅 using the Morpher platform - a trade that is currently unavailable on the main exchange! Onions can be traded directly without the need for exchanges or middlemen. https://lnkd.in/eYh2s2QB That’s all for this week- see you next week for more updates! 👋 #Award #CardiovascularDisease #Challenge #AI #Cancer #Oncology #Trading
Identifiez-vous pour afficher ou ajouter un commentaire
-
-
One of the highlights of my job is impact stories, research articles exploring how University of Adelaide researchers are advancing healthcare, shaping society, and protecting our environment. Read a few recent pieces below! 🩷 Breast cancer breakthroughs: dual innovations spark hope - https://rb.gy/x8h5td 📱 Digital age: screen time’s effect on language learning in children - https://rb.gy/inu8pc 🪸 Restoring lost reefs: bringing oysters back from extinction - https://rb.gy/oj2uvh
Identifiez-vous pour afficher ou ajouter un commentaire
-